Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y H Su

Showing results (71-80 of 75) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 75 results.
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]|August 20, 2019
[Current practice of implant-based breast reconstruction: results from China national practice questionnaire survey]R Guo, B Q Xiu, Y H Su, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|December 1, 2020
[Current trend of breast cancer neoadjuvant treatment in China: a cross-sectional study]J Wang, B Q Xiu, R Guo, et al.
Oncogene|August 22, 2017
miR-520h is crucial for DAPK2 regulation and breast cancer progressionC-M Su, M-Y Wang, C-C Hong, et al.
Oncogene|May 19, 2015
miR-520h is crucial for DAPK2 regulation and breast cancer progressionC-M Su, M-Y Wang, C-C Hong, et al.
Oncogene|March 14, 2012
MiR-520h-mediated FOXC2 regulation is critical for inhibition of lung cancer progression by resveratrolY-H Yu, H-A Chen, P-S Chen, et al.
Pageof 8

Showing results (71-80 of 75) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 75 results.
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]|August 20, 2019
[Current practice of implant-based breast reconstruction: results from China national practice questionnaire survey]R Guo, B Q Xiu, Y H Su, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|December 1, 2020
[Current trend of breast cancer neoadjuvant treatment in China: a cross-sectional study]J Wang, B Q Xiu, R Guo, et al.
Oncogene|August 22, 2017
miR-520h is crucial for DAPK2 regulation and breast cancer progressionC-M Su, M-Y Wang, C-C Hong, et al.
Oncogene|May 19, 2015
miR-520h is crucial for DAPK2 regulation and breast cancer progressionC-M Su, M-Y Wang, C-C Hong, et al.
Oncogene|March 14, 2012
MiR-520h-mediated FOXC2 regulation is critical for inhibition of lung cancer progression by resveratrolY-H Yu, H-A Chen, P-S Chen, et al.
Pageof 8